Alkeus Pharmaceuticals, Inc. Employee Directory
Biotechnology ResearchMassachusetts, United States51-200 Employees
Alkeus Pharmaceuticals, Inc. is a mid-sized biotechnology company based in Cambridge, Massachusetts, focused on preserving sight for people affected by retinal diseases. Founded in 2010, it positions itself as a late-stage biopharmaceutical company pursuing therapies for conditions with significant unmet need. The company is advancing an investigational oral therapy, gildeuretinol, intended to treat diseases such as Stargardt disease and Geographic Atrophy. Alkeus engages with the scientific and medical communities through presentations at major ophthalmology conferences to share clinical data on gildeuretinol. In 2026, the company announced data presentations at the ARVO annual meeting, illustrating ongoing clinical development and collaboration with researchers.